Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$3.89 - $9.43 $119,333 - $289,284
-30,677 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$8.75 - $30.71 $268,423 - $942,090
30,677 New
30,677 $287,000
Q1 2021

May 17, 2021

SELL
$27.81 - $53.64 $601,502 - $1.16 Million
-21,629 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$37.09 - $54.5 $802,219 - $1.18 Million
21,629 New
21,629 $1.04 Million

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $431M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.